Back to Search
STEVEN WAGGONER, MD
MD
Gynecologic Oncology Physician
NPI: 1851322150IndividualAccepts Medicare
Specialties, Licenses & Credentials
Gynecologic Oncology PhysicianPrimary
Obstetrics & Gynecology — Gynecologic Oncology
Code: 207VX0201X
35-081437(OH)
Education
UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE
Class of 1984
Research & Publications (20)
Association between cigarette smoking and prognosis in locally advanced cervical carcinoma treated with chemoradiation: a Gynecologic Oncology Group study.
PMID 16815535·Gynecol Oncol·2006
4-observational
Population genetic study of the brain-derived neurotrophic factor (BDNF) gene.
PMID 19255578·Mol Psychiatry·2010
8-other
Depletion of the poly(C)-binding proteins alphaCP1 and alphaCP2 from K562 cells leads to p53-independent induction of cyclin-dependent kinase inhibitor (CDKN1A) and G1 arrest.
PMID 19211566·J Biol Chem·2009
8-other
Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group.
PMID 19332726·J Clin Oncol·2009
3-trial
Chemotherapy Administration during Pelvic Radiation for Cervical Cancer Patients Aged >/=55 Years in the SEER-Medicare Population.
PMID 19259335·J Oncol·2008
8-other
Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial.
PMID 18243282·Gynecol Oncol·2008
2-rct
Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy.
PMID 18783287·Technol Cancer Res Treat·2008
5-case
Role of complement in immune regulation and its exploitation by virus.
PMID 18158725·Viral Immunol·2007
6-review
Identification of EFHC2 as a quantitative trait locus for fear recognition in Turner syndrome.
PMID 17164267·Hum Mol Genet·2007
8-other
A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: a gynecologic oncology group study.
PMID 17597196·Gynecol Oncol·2007
3-trial
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production.
PMID 17881511·J Leukoc Biol·2007
8-other
Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia.
PMID 17033966·Am J Hum Genet·2006
4-observational
Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study.
PMID 17096437·Cancer·2006
4-observational
Phase II trial of weekly paclitaxel (80 mg/m2) in platinum and paclitaxel-resistant ovarian and primary peritoneal cancers: a Gynecologic Oncology Group study.
PMID 16325893·Gynecol Oncol·2006
3-trial
Fas ligand is responsible for CXCR3 chemokine induction in CD4+ T cell-dependent liver damage.
PMID 16670334·J Immunol·2006
7-preclinical
SOCS1 and SOCS3 are targeted by hepatitis C virus core/gC1qR ligation to inhibit T-cell function.
PMID 16873288·J Virol·2006
8-other
gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway.
PMID 16177118·J Immunol·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 11100 EUCLID AVE
CLEVELAND, OH 44106 - Phone
- (216) 844-3941
Quick Facts
- NPI
- 1851322150
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile